IHC - Calcitonin (IHC)

IHC – Calcitonin (IHC) Test

The IHC Calcitonin Test is a specialized immunohistochemistry (IHC) diagnostic test used to detect calcitonin protein expression in tissue samples. Calcitonin is a hormone produced by the parafollicular C-cells of the thyroid gland and serves as an important biomarker for diagnosing medullary thyroid carcinoma (MTC) and other rare neuroendocrine tumors.

This test plays a crucial role in confirming the diagnosis of thyroid C-cell neoplasms, distinguishing medullary thyroid carcinoma from other thyroid malignancies, and supporting tumor classification during pathological evaluation.

The IHC Calcitonin test is commonly used in evaluating:

• Medullary thyroid carcinoma (MTC)
• C-cell hyperplasia
• Neuroendocrine tumors with calcitonin expression
• Differential diagnosis of thyroid tumors

The test is performed on FFPE (Formalin-Fixed Paraffin-Embedded) tissue biopsy or surgical specimens using advanced antibody staining techniques. Expert pathologists examine stained tissue under a microscope to assess calcitonin protein expression and identify abnormal C-cell activity.

Calcitonin positivity strongly supports medullary thyroid carcinoma diagnosis and helps oncologists guide treatment decisions, prognosis assessment, and genetic counseling where hereditary syndromes such as MEN2 (Multiple Endocrine Neoplasia Type 2) are suspected.

This test is especially valuable when routine histopathology findings are inconclusive or when confirmation of neuroendocrine thyroid tumor origin is required.

Benefits of the Test

• Detects calcitonin protein expression accurately
• Supports medullary thyroid carcinoma diagnosis
• Helps classify thyroid tumors
• Assists differential diagnosis
• Improves pathology diagnostic precision
• Supports personalized treatment planning

Why Doctors Recommend This Test

Doctors commonly recommend the Calcitonin IHC Test when:

• Medullary thyroid carcinoma is suspected
• Thyroid tumor subtype clarification is needed
• C-cell hyperplasia evaluation is required
• Routine biopsy findings are inconclusive
• Neuroendocrine tumor confirmation is necessary
• Hereditary thyroid cancer assessment is needed
• Treatment planning depends on exact diagnosis
• Advanced oncopathology confirmation is required

This test improves diagnostic confidence for accurate thyroid cancer management.

Preparation Before the Test

Preparation usually includes:

• Submission of FFPE tissue block or unstained slides
• Previous pathology reports
• Relevant thyroid imaging and clinical records
• Proper tissue labeling and packaging
• Laboratory authorization documentation

No fasting or direct patient preparation is required.

Normal Reporting Time

The normal reporting time for the Calcitonin IHC Test is usually 4–7 working days, depending on staining complexity and expert interpretation requirements.

Who Should Take This Test?

This test is recommended for:

• Patients with suspected thyroid tumors
• Individuals undergoing medullary thyroid carcinoma evaluation
• Patients requiring thyroid tumor classification
• Individuals with unclear biopsy diagnosis
• Oncology patients under specialist care
• Patients requiring advanced immunohistochemistry confirmation

At Focus Diagnostics Hyderabad, advanced immunohistochemistry technology and expert oncopathology specialists ensure highly accurate Calcitonin IHC reports for reliable diagnosis and personalized thyroid cancer treatment planning.